Every 10-Q that Nordson Corp (NDSN) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow NDSN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NDSN filings page.
Nordson Corporation (NDSN) reported solid growth for the quarter and nine months ended July 31, 2026. Quarterly sales rose to $817.7 million, up 10.3%, with net income of $152.8 million and diluted EPS of $2.73, up 23.0% year over year. Nine-month sales reached $2.23 billion, up 9.2%, while net income grew 21.2% to $403.5 million and diluted EPS increased 23.5% to $7.20. Growth was broad-based, led by the Advanced Technology Solutions segment and strong Asia Pacific demand. Gross margin improved slightly, interest expense declined on lower average debt, and operating cash flow strengthened to $570.5 million, supporting debt reduction, dividends, and share repurchases. Total debt outstanding decreased to about $1.74 billion, with a new $1.2 billion revolving credit facility and a $1.2 billion commercial paper program providing additional liquidity.
Nordson Corporation reported solid growth for the quarter and first half of fiscal 2026. For the three months ended April 30, 2026, sales were $740.8 million, up 8.5% from a year ago, with net income of $117.3 million and diluted EPS of $2.09. Operating profit rose 16.9% as all three segments grew, led by Advanced Technology Solutions and Medical and Fluid Solutions, while gross margin stayed around 55%.
For the first six months, sales reached $1.41 billion, up 8.6%, and net income increased 21.1% to $250.7 million, or $4.47 per diluted share. Interest expense declined on lower average debt, and other income benefited from gains on a minority investment, partly offset by a $24.0 million U.S. pension settlement loss. Operating cash flow was strong at $321.1 million, supporting $107 million of debt repayment, $129.3 million of share repurchases, and $91.6 million of dividends, while maintaining access to a $1.2 billion revolving credit facility.
Nordson Corporation reported strong quarterly growth. For the three months ended January 31, 2026, sales rose 8.8% to $669,461 thousand, driven by demand in Industrial Precision Solutions and a 23.2% organic increase in Asia Pacific sales.
Net income increased 40.9% to $133,382 thousand, and diluted earnings per share grew to $2.38 from $1.65, helped by higher operating profit, lower interest expense and an unrealized gain of $22,238 thousand on a minority investment. Gross margin edged up to 54.7%, while segment EBITDA improved in Medical and Fluid Solutions and Advanced Technology Solutions.
Operating cash flow was $140,428 thousand, supporting $86,001 thousand of share repurchases and $45,786 thousand of dividends. The company ended the quarter with cash of $120,392 thousand and $2,004,312 thousand of gross long-term debt, including $400,000 thousand drawn on a new $1,200,000 thousand revolving credit facility maturing in 2031.
Nordson Corporation (NDSN) reported interim results and disclosures for the nine months ended July 31, 2025. Net income was stated as $332,840 and $5.83 per diluted share for the nine months, a 3.6% decrease in net income and a $0.16 decrease in diluted EPS versus the prior year period. The company completed the August 21, 2024 acquisition of Atrion, recording $494,279 of goodwill and $129,600 of identifiable intangible assets; the purchase price allocation remained preliminary as of July 31, 2025. Cash and liquidity remain strong with $147,788 cash on hand, $516,264 cash provided by operations for the nine months and $824,120 of available borrowing capacity. The company had outstanding borrowings of $280,000 on a term loan and $243,000 on its revolving facility, with a weighted-average interest rate of 5.48% on its credit facilities. The effective tax rate was 19.7% for the nine months; excluding a discrete divestiture tax item the three- and nine-month rates were lower. Foreign-currency forward contracts produced net losses in the period and net investment hedges showed translation losses recorded in AOCI. Management concluded disclosure controls were effective and noted no material changes in internal control over financial reporting.